| Synonyms: | |
| Status: | Approved (2013) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC14 |
| UNII: | SE2KH7T06F |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Receptor protein-tyrosine kinase erbB-2 binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Inflammatory Breast Neoplasms | 3 | D058922 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
| Neoplasm Metastasis | 2 | D009362 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1018448-65-1 |
| ChEMBL | CHEMBL1743082 |
| FDA SRS | SE2KH7T06F |
| Guide to Pharmacology | 6928 |
CONTENTS